To investigate whether or not PFD requires the NF‐κB pathway to protect against SILI, we analyzed the effects of addition of PMA, the agonist of NF‐κB signaling pathway, on SILI. This evidence concerns the gene NFKB1 and polyostotic fibrous dysplasia.